Novel nanovectors as liver targeting MRI contrast agents
نویسندگان
چکیده
منابع مشابه
Development of 153Sm-DTPA-SPION as a theranostic dual contrast agents in SPECT/MRI
Objective(s): This study describes the preparation, biodistribution of 153Sm-DTPA-SPION after intravenous injection in rats. Materials and Methods: The chelator DTPA dianhydride was conjugated to SPION using a small modification of the well-known cyclic anhydride method. Conjugation was done at a 1: 4 (SPION: ccDTPA) molar ratio. Conjugation reaction was purified with magnetic assorting column...
متن کاملSynthesis and Characterization of Chitosan Coated Manganese Zinc Ferrite Nanoparticles as MRI Contrast Agents
Manganese zinc ferrite nanoparticles (MZF NPs) were synthesized by using a direct, efficient and environmental friendly hydrothermal method. To improve the colloidal stability of MZF NPs for biomedical applications, NPs were coated with chitosan by ionic gelation technique using sodium tripolyphosphate (TPP) as crosslinker. The synthesized NPs were characterized by X ray diffraction (XRD) analy...
متن کاملA novel MRI contrast agent synthesized by ion exchange method
Objective: In this study, the zeolite-coated iron oxide nanoparticles were evaluated as MRI contrast agent and effect of the nanocomposite synthesis method on MRI contrast was tested. Materials and Methods: Ion exchange method was used for synthesis of iron oxide-zeolite and the as prepared nanocomposite was characterized by XRD, FESEM and TEM. The nanocomposite toxicity in the cell culture, a...
متن کاملNovel Metalloporphyrins as Molecular MR Contrast Agents
Introduction: To date, no imaging methodology exists which can image prostate cancer in vivo with sufficient sensitivity and specificity for diagnostic utility. As a consequence, urological surgeons and oncologists proceed with treatment strategies based on ‘blind’ biopsy tissue specimens and limited diagnostic evaluations using conventional MRI and ultrasound. In these experiments, we have inv...
متن کاملPPARγ Inhibitors as Novel Tubulin-Targeting Agents
The microtubule-targeting agents (MTAs) are a very successful class of cancer drugs with therapeutic benefits in both hematopoietic and solid tumors. However, resistance to these drugs is a significant problem. Current MTAs bind to microtubules, and/or to their constituent tubulin heterodimers, and affect microtubule polymerization and dynamics. The PPARgamma inhibitor T0070907 can reduce tubul...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Chinese Pharmaceutical Sciences
سال: 2011
ISSN: 1003-1057
DOI: 10.5246/jcps.2011.02.013